Clinical and serological profile of systemic sclerosis in Tunisia: A retrospective observational study.


Journal

Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 02 05 2017
revised: 19 12 2017
accepted: 30 07 2019
pubmed: 28 10 2019
medline: 18 12 2019
entrez: 27 10 2019
Statut: ppublish

Résumé

The Prevalence of systemic sclerosis (SSc) and different clinical subsets varies across the world. Few data have been published on SSc patients in North Africa. Our objective was to describe a SSc cohort in south of Tunisia and to compare clinical findings, disease subsets and antibodies with other international SSc populations. In this retrospective observational study, Folders of patients with SSc seen in the internal medicine section of the Hedi Chaker Hospital between 2000 and 2013 were retrospectively analyzed. The diagnosis of SSc was retained according to ACR/EULAR 2013 criteria. Patients were classified into diffuse cutaneous SSc and limited cutaneous SSc subsets. Comparison with other cohorts was made based on published information. A higher female: male ratio (8:1) and a higher diffuse subset prevalence (82%) was found in this Tunisian cohort comparing with others. We also found a lower prevalence of calcinosis and anticentromere antibodies. Within each subset, diffuse cutaneous and limited cutaneous scleroderma clinical findings were similar with other systemic sclerosis populations except for a very low prevalence in renal crisis and pulmonary hypertension. Our results indicate overlap syndrome defined as scleroderma associated with others connective tissue disorder's is a relatively common condition. With slight variations, perhaps due to genetic, environmental or referral factors, SSc in this cohort appears to be similar to that described in other part of the world.

Identifiants

pubmed: 31653544
pii: S0755-4982(19)30406-3
doi: 10.1016/j.lpm.2019.07.037
pii:
doi:

Substances chimiques

DNA Topoisomerases, Type I EC 5.99.1.2

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e284-e291

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Raida Ben Salah (R)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia. Electronic address: raidabensalah@yahoo.fr.

Faten Frikha (F)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Hend Hachicha (H)

Habib Bourguiba Hospital, laboratory of immunology, 3029 Sfax, Tunisia.

Imen Chabchoub (I)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Chifa Dammak (C)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Mona Snoussi (M)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Moez Jallouli (M)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Sameh Marzouk (S)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Hatem Masmoudi (H)

Habib Bourguiba Hospital, laboratory of immunology, 3029 Sfax, Tunisia.

Zouhir Bahloul (Z)

Hedi Chaker Hospital, department of internal medicine, 3029 Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH